Furthermore, we identified that circMET could promote the progression of NSCLC cells by sponging oncogenic miR-145-5p [18, 19] to upregulate chemokine (C-X-C motif) ligand 3 (CXCL3) [20, 21] expression. This evidence concerns the gene CXCL3 and non-small cell lung carcinoma.